Quadrant Capital Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.71K	Hold	705	–	–	﹤0.01%	2297
2025 Q4	$5.5K	Hold	705	–	–	﹤0.01%	2348
2025 Q3	$5.35K	Buy	+705	New	+$5.87K	﹤0.01%	2311
2025 Q2	–	Sell	-529	Closed	-$3.97K	–	1478
2025 Q1	$3.97K	Hold	529	–	–	﹤0.01%	2400
2024 Q4	$3.98K	Hold	529	–	–	﹤0.01%	2359
2024 Q3	$4.02K	Hold	529	–	–	﹤0.01%	2364
2024 Q2	$3.27K	Sell	529 -156	-23%	-$861	﹤0.01%	2393
2024 Q1	$3.48K	Buy	685 +22	+3%	+$124	﹤0.01%	2401
2023 Q4	$3.97K	Buy	663 +330	+99%	+$1.91K	﹤0.01%	2336
2023 Q3	$2.36K	Buy	+333	New	+$2.39K	﹤0.01%	2350
2023 Q2	–	Sell	-211	Closed	-$1.76K	–	2696
2023 Q1	$1.76K	Buy	+211	New	+$2.03K	﹤0.01%	2449